Fish oil may improve triglyceride concentrations in patients with various renal diseases. The mechanism is unknown but may involve an alteration in clearance kinetics associated with VLDL, the primary lipid transport particle. Since abnormalities in triglyceride metabolism are very common in patients with nephrotic syndrome, this study evaluated whether a diet enriched with fish oil compared with an isocaloric diet enriched with olive oil improves triglyceride concentrations, and whether it does so through an alteration in VLDL particle kinetics. VLDL kinetics were measured after 5 weeks of either 9 grams of fish oil in the diet or 9 grams of olive oil in the diet in subjects with nephrotic range proteinuria. VLDL particle apo B-100 protein was labeled with a stable isotope of leucine (15N-leucine) by the flooding dose technique. Serum was harvested in a standard pharmaco-kinetic pattern over 2 weeks to determine the rate of appearance (Ra) and rate of disappearance (Rd) of labeled VLDL apo B-100 protein.Patients with nephrotic syndrome often have abnormalities in lipid metabolism. These may arise from increased synthesis of lipoproteins by the liver. This study is designed to test the effect of a dietary adjustment using fish oil versus olive oil (isocaloric diets) to examine the effect of dietary lipid composition on the synthesis of VLDL using a stable isotope, N15-luecine, as a tracer of VLDL kinetics and metabolism in subjects with nephrotic syndrome who consume a fish oil or olive oil enhanced diet for 6 weeks intervals.

Project Start
1998-12-01
Project End
1999-11-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
39
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Khalili, Mandana; Shuhart, Margaret C; Lombardero, Manuel et al. (2018) Relationship Between Metabolic Syndrome, Alanine Aminotransferase Levels, and Liver Disease Severity in a Multiethnic North American Cohort With Chronic Hepatitis B. Diabetes Care 41:1251-1259
Thomas, Bernadette; Matsushita, Kunihiro; Abate, Kalkidan Hassen et al. (2017) Global Cardiovascular and Renal Outcomes of Reduced GFR. J Am Soc Nephrol 28:2167-2179
Ojiro, Keisuke; Qu, Xiaowang; Cho, Hyosun et al. (2017) Modulation of Hepatitis C Virus-Specific CD8 Effector T-Cell Function with Antiviral Effect in Infectious Hepatitis C Virus Coculture Model. J Virol 91:
Di Bisceglie, A M; Lombardero, M; Teckman, J et al. (2017) Determination of hepatitis B phenotype using biochemical and serological markers. J Viral Hepat 24:320-329
Lok, A S; Ganova-Raeva, L; Cloonan, Y et al. (2017) Prevalence of hepatitis B antiviral drug resistance variants in North American patients with chronic hepatitis B not receiving antiviral treatment. J Viral Hepat 24:1032-1042
Leonard, Mary B; Shults, Justine; Long, Jin et al. (2016) Effect of Low-Magnitude Mechanical Stimuli on Bone Density and Structure in Pediatric Crohn's Disease: A Randomized Placebo-Controlled Trial. J Bone Miner Res 31:1177-88
Ricordi, Camillo; Goldstein, Julia S; Balamurugan, A N et al. (2016) National Institutes of Health-Sponsored Clinical Islet Transplantation Consortium Phase 3 Trial: Manufacture of a Complex Cellular Product at Eight Processing Facilities. Diabetes 65:3418-3428
Evon, Donna M; Wahed, Abdus S; Johnson, Geoffrey et al. (2016) Fatigue in Patients with Chronic Hepatitis B Living in North America: Results from the Hepatitis B Research Network (HBRN). Dig Dis Sci 61:1186-96
Park, Jang-June; Wong, David K; Wahed, Abdus S et al. (2016) Hepatitis B Virus--Specific and Global T-Cell Dysfunction in Chronic Hepatitis B. Gastroenterology 150:684-695.e5
Hering, Bernhard J; Clarke, William R; Bridges, Nancy D et al. (2016) Phase 3 Trial of Transplantation of Human Islets in Type 1 Diabetes Complicated by Severe Hypoglycemia. Diabetes Care 39:1230-40

Showing the most recent 10 out of 423 publications